Incidence of genitourinary complications following radiation therapy for localised prostate cancer - Takeaways - MDSpire

Incidence of genitourinary complications following radiation therapy for localised prostate cancer

  • By

  • Rowan V. David

  • Arman A. Kahokehr

  • Jason Lee

  • David I. Watson

  • John Leung

  • Michael E. O’Callaghan

  • August 11, 2022

  • 0 min

Share

  • 1

    Prostate cancer is the second most common cancer in men, with 94% of cases being curable localized disease.

  • 2

    Radiotherapy is a prevalent treatment for localized prostate cancer, but late genitourinary toxicity incidence is poorly understood.

  • 3

    This study aimed to determine the cumulative incidence of treatment-related genitourinary toxicity following external beam radiotherapy.

  • 4

    A population-based cohort study was conducted in South Australia, linking patient records to identify treatment-related genitourinary toxicity.

  • 5

    The study assessed various demographic and treatment-related factors to understand their impact on genitourinary toxicity outcomes.

Original Source(s)

Incidence of genitourinary complications following radiation therapy for localised prostate cancer

  • by Rowan V. David, Arman A. Kahokehr, Jason Lee, David I. Watson, John Leung, Michael E. O’Callaghan

  • August 11, 2022

Related Content

One-year clinical outcomes of MR-guided stereotactic body radiation therapy with rectal spacer for patients with localized prostate cancer

Radiotherapy in metastatic bladder cancer

Beyond Treatment Volume: When Pelvic Radiotherapy May Still Matter in High-Risk Localised Prostate Cancer